| Financial Year |
March 31 2023 |
| Monetary Funds |
565,811,508.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
376,000.00 |
| Accounts Receivable |
1,200,109,235.76 |
| Advances to Suppliers |
93,197,512.25 |
| Other Receivables |
310,254,431.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
92,757,525.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
181,236,259.78 |
| Total Current Assets |
5,448,442,687.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
388,441,585.56 |
| Investment Properties |
67,606,421.37 |
| Fixed Assetes |
659,990,315.20 |
| Under-construction Projects |
141,194,916.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
3,044,266.26 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
307,781,533.82 |
| R&D expenses |
5,019,456.94 |
| Goodwill |
32,667,574.29 |
| Long-Term Deferred and Prepaid Expenses |
12,916,302.15 |
| Deferred Income Tax Assets |
105,133,137.65 |
| Other Non-Current Assets |
1,287,097,214.50 |
| Sub-Total of Non-Current Assets |
3,359,265,660.67 |
| Total Assets |
8,807,708,347.71 |
| Short-Term Loans |
1,161,232,002.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
529,340,011.10 |
| Accounts Payable |
2,531,471,224.54 |
| Accounts Received In Advance |
30,004,369.89 |
| Employee Compensation Payable |
47,522,226.26 |
| Taxes Payable |
66,272,083.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
812,340,420.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
108,874,012.24 |
| Other Current Liabilities |
222,170,840.06 |
| Sub-Total of Current Liabilities |
5,917,413,995.01 |
| Long-term Loans |
958,987,338.68 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
22,646,175.95 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
422,625.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,019,079,752.94 |
| Total Liabilities |
6,936,493,747.95 |
| Paid-In Capital(Or Share Stock) |
699,623,237.00 |
| Capital Surplus |
399,256,374.94 |
| Surplus Reserve |
78,139,511.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
314,966,188.45 |
| Minority Stockholder's Interest |
332,723,532.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,538,491,067.28 |
| Owner's Equity（Stockholder's Equity） |
1,871,214,599.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,807,708,347.71 |
